Q&A: FDA Panel Member Tells Healthline Why He Resigned Over Alzheimer’s Drug Approval
Similar Posts
Walter L. Douglas, Jr. Joins Morehouse School of Medicine as Executive Vice President for Operations and Business Affairs
Douglas joins MSM after serving as the Vice President and Chief Operating Officer of Neighborhood Health Services Corporation Morehouse…
Global Experts and Leaders Devise a New Blueprint for Kidney Care
This week, the International Society of Nephrology (ISN) convened a meeting with global kidney experts to develop a new,…
Amendola Communications Expands East Coast Presence with Seasoned Senior Executives
Heather Caouette of eClinicalWorks and Julie Donnelly of Boston Business Journal to lead key client Healthcare IT initiatives Amendola…
Diameter Health Names Former Anthem BCBS Executive Jill Hummel to Board as an Independent Director
Hummel Brings 20 Years of Experience in Health Plan Innovation to Deep Bench of Independent, Investor and Company Leadership…
The Courage in Compassion:
My Mother’s Greatest Giftby Irene Allison “Courage and compassion are two sides of the same coin. Compassion without courage is not genuine….
